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here is increasing evidence that ubiquitination of
receptors provides an important endosomal sorting
signal. Here we report that mammalian class E vac-
uolar protein-sorting (vps) proteins recognize ubiquitin.
Both tumor susceptibility gene 101 (TSG101)/human VPS
(hVPS)28 and hepatocyte growth factor receptor substrate
(Hrs) cytosolic complexes bind ubiquitin-agarose. TSG101
and hVPS28 are localized to endosomes that contain inter-
nalized EGF receptor and label strongly for ubiquitinated
T
 
proteins. Microinjection of anti-hVPS28 speciﬁcally retards
EGF degradation and leads to endosomal accumulation of
ubiquitin–protein conjugates. Likewise, depletion of TSG101
impairs EGF trafﬁcking and causes dramatic relocalization
of ubiquitin to endocytic compartments. Similar defects are
found in cells overexpressing Hrs, further emphasizing the
links between class E protein function, receptor trafﬁcking,
and endosomal ubiquitination.
 
Introduction
 
Ligand-induced down-regulation of mitogenic receptors in-
volves their endocytosis via clathrin-coated vesicles. Mitogenic
receptors are then sorted within the endosomal system to the
lysosomal pathway. Sorting includes the relocalization of
receptors to the internal vesicles of late endosomes or multi-
vesicular bodies, which then fuse with the lysosome directly.
Efficient endocytosis is regulated both by receptor tyrosine
protein kinase activity and by ubiquitination (Waterman
and Yarden, 2001). Consistent with this, the EGF receptor
(EGFR)*–negative regulator c-Cbl was identified as an E3
ubiquitin ligase specific for autophosphorylated receptor
tyrosine kinases (Joazeiro et al., 1999; Levkowitz et al.,
1999). Receptor tyrosine kinase activity and ubiquitination
have also been implicated in receptor sorting, since kinase-
defective EGFR is recycled to the cell surface more efficiently
than wild-type receptor (Felder et al., 1990) and ubiqui-
tin ligase–defective Cbl mutants enhance EGFR recycling
(Levkowitz et al., 1999).
Studies in yeast have identified a family of proteins important
for endosomal sorting. Class E vacuolar protein-sorting (
 
vps
 
)
mutants fail to transport newly synthesized hydrolases effi-
ciently to the vacuole. Instead, hydrolases accumulate with
endocytosed receptors in an exaggerated perivacuolar class E
compartment (Raymond et al., 1992; Piper et al., 1995;
Rieder et al., 1996). This compartment is unable to sort
markers to internal vesicles, indicating that both receptor
sorting and the inward invagination of membrane are directly
or indirectly effected by class E vps proteins (Odorizzi et al.,
1998). Mammalian homologues of class E vps proteins have
been identified, including hepatocyte growth factor receptor
substrate (Hrs; related to Vps27p) (Komada et al., 1997),
tumor susceptibility gene 101 (TSG101; related to Vps23p)
(Babst et al., 2000), and human vacuolar protein sorting
(hVPS)28 (Bishop and Woodman, 2001). The precise roles
that these proteins play in receptor sorting remain unclear.
Given the putative role for ubiquitination in mitogenic
receptor sorting, we were intrigued by reports that the class
E protein Vps23p (Babst et al., 2000) and its mammalian
orthologue TSG101 (Li and Cohen, 1996) contain a domain
resembling E2 ubiquitin-conjugating (Ubc) enzymes, albeit
lacking the catalytic cysteine residue (Koonin and Abagyan,
1997; Ponting et al., 1997). Therefore, TSG101 might be a
candidate for coupling the recognition of ubiquitinated
moietie(s) to the sorting of receptors. This hypothesis
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formed the basis for the work presented in this article. Emr
and colleagues have demonstrated independently that Vps23p
assists the biosynthetic sorting of ubiquitinated vacuolar
protease precursors (Katzmann et al., 2001).
 
Results
 
Two mammalian class E vps complexes bind 
independently to ubiquitin
 
Given the presence of a Ubc enzyme–like domain within
TSG101 (Koonin and Abagyan, 1997; Ponting et al., 1997),
we examined whether TSG101 might recognize ubiquitin.
As a control, we measured the binding of the Ubc (E2) en-
zyme Ubc1 (Hershko et al., 1983). Ubc1 did not bind to
ubiquitin-agarose when ATP was absent but bound ubiq-
uitin-agarose (but not glutathione [GSH]-agarose) in the
presence of ATP, which enables ubiquitin to bind covalently
to E2 enzymes via the activity of cytosolic ubiquitin-activat-
ing (E1) enzymes (Hershko et al., 1983). Cytosolic TSG101
and hVPS28 form part of a high molecular weight complex
(Babst et al., 2000; Bishop and Woodman, 2001). Both
TSG101 and hVPS28 bound specifically to ubiquitin-aga-
rose with comparable efficiency to Ubc1 (Fig. 1 A). How-
ever, binding was ATP independent, indicating that it did
not require covalent modification of the components of the
complex or other TSG101–hVPS28-interacting proteins.
Binding was specific, since little binding of tubulin was de-
tected (Fig. 1 A). In addition, binding of TSG101 and hVPS28
was substantially reduced by inclusion of soluble ubiquitin
(Fig. 1 B).
In vitro–translated TSG101 also interacted with ubiquitin-
agarose. Binding required the Ubc domain of TSG101, since
TSG101
 
 
 
Ubc failed to bind and the Ubc domain alone
bound to the same extent as full-length protein. In contrast,
deletion of the helical domain required for the interaction of
TSG101 with hVPS28 (Bishop and Woodman, 2001) did
not affect its binding to ubiquitin. In vitro–translated
hVPS28 did not bind to ubiquitin-agarose (unpublished
data). Together, these data are consistent with the complex
binding to ubiquitin via the Ubc domain of TSG101,
though we cannot rule out the possibility that this occurs
through an intermediary factor rather than being direct.
The activities of class E vps proteins are likely to be linked,
raising the possibility that other class E proteins might rec-
ognize ubiquitin. In particular, Hrs localizes to the sorting
endosome (Komada et al., 1997; Raiborg et al., 2001) and
interacts indirectly with a deubiquitinating enzyme (Kato et
al., 2000). Indeed, Hrs binds ubiquitin (Fig. 1 A). As for
TSG101, binding of cytosolic Hrs to ubiquitin was ATP in-
dependent and was reduced by inclusion of soluble ubiq-
uitin (Fig. 1 B). Hrs binding was not mediated via the
TSG101–hVPS28 complex. When cytosol was depleted of
TSG101 with anti-hVPS28, there was little depletion of Hrs
(Fig. 1 D, left). Therefore, Hrs does not appear to interact
with the TSG101 complex in solution. Additionally, deple-
tion of TSG101 had little impact on the association of cyto-
solic Hrs with ubiquitin (Fig. 1 D, right). Furthermore, in
vitro–translated Hrs bound to ubiquitin-agarose specifically
(Fig. 1 E). During the course of our studies, a putative ubiq-
uitin-interacting motif (UIM) was identified within Hrs,
with two such motifs in Vps27p (Hofmann and Falquet,
2001). Deletion of the UIM sharply reduced the efficiency
with which Hrs bound ubiquitin (Fig. 1 E). Binding was
also reduced by a double point mutation in which two
charged amino acids within the UIM were substituted.
Hence, the conserved UIM is mainly responsible for the in-
Figure 1. Mammalian class E vps proteins bind ubiquitin. (A) 
ATP-depleted HeLa cytosol was incubated with GSH- (lanes 1 and 
2) or ubiquitin-agarose (lanes 3 and 4) with (lanes 1 and 3) or with-
out (lanes 2 and 4) 1 mM Mg-ATP. Bound fractions were analyzed 
by Western blotting. 25% of the input was also blotted (T). (B) Cytosol 
was incubated with ubiquitin-agarose after preincubating for 15 min 
without (lane 1) or with (lane 2) 1 mg soluble ubiquitin. Bound 
fractions were analyzed as above. (C) Equal counts of in vitro–
translated TSG101 (lanes 1 and 5), TSG101 Ubc (lanes 2 and 6), 
the Ubc domain alone (lanes 3 and 7), or TSG101 Hx (lanes 4 and 
8) were incubated with ubiquitin- (lanes 1–4) or GSH-agarose (lanes 
5–8). Bound fractions were analyzed by PAGE and phosphorimaging. 
(D) HeLa cytosol was immunodepleted using either preimmune or 
anti-hVPS28 IgG. The resulting cytosols were Western blotted for 
Hrs and TSG101 (left). Parallel samples were incubated with 
ubiquitin-agarose, and bound material was Western blotted (right). 
(E) Equal counts of in vitro–translated Hrs, Hrs UIM, and Hrs(AQ) 
were incubated with GSH- or ubiquitin-agarose (left). Translation 
products, run on a separate gel, are also shown. Samples were 
analyzed as above. 
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teraction that we observe. A second UIM is present within
Vps27p but is weakly conserved in Hrs. This may contribute
to the residual ubiquitin binding we observed.
 
The TSG101 complex is localized to ubiquitin-enriched 
EGF-containing endosomes
 
Cells expressing reduced levels of TSG101 are impaired in
mitogenic receptor down-regulation, consistent with the
structural similarity between TSG101 and Vps23p (Babst et
al., 2000). However, TSG101 has been implicated in several
cellular processes, most likely involving its interaction with
ubiquitinated substrate(s) (see Discussion). Hence, deple-
tion of TSG101 may interfere with receptor sorting indi-
rectly by allowing the accumulation of ubiquitinated inter-
mediates in other cellular pathways and hence reducing the
levels of available free ubiquitin and/or ubiquitin-interacting
components. By analogy, it has been demonstrated by sev-
eral laboratories that proteasomal inhibitors dramatically re-
duce cellular free ubiquitin levels, most likely by preventing
the deubiquitination of proteasomal substrates (Patnaik et
Figure 2. TSG101 and hVPS28 are localized to ubiquitin-rich EGF-positive 
endosomes. (A) A431 cells were starved overnight in serum-free medium and 
either left untreated (no EGF) or incubated with 0.4  g/ml EGF at 4 C followed 
by the indicated time at 37 C. Cell lysates were immunoprecipitated with 
control (left) or anti-EGFR antibody (right). Bound fractions were Western 
blotted with anti-EGFR (top) or antiubiquitin (FK2; bottom). The band detected 
in the FK2 blot running just below the EGFR is an artifact, since it is found in 
EGFR immunoprecipitates from cells lacking EGFR (unpublished data). (B) 
Oregon green EGF was bound to A431 cells and internalized as indicated. 
Cells were chilled, incubated with saponin before fixation, and then analyzed 
for EGF content (left) and stained with FK2 antibody (right). (C) A431 cells 
were either left untreated (left) or had Oregon green EGF internalized for 60 
min (right). Cells were chilled and incubated with saponin before fixation and 
then analyzed for EGF (green) or stained (red) for the following markers: EEA1, 
polyubiquitin–protein conjugates (FK1), TSG101, or hVPS28. 
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al., 2000; Schubert et al., 2000; Strack et al., 2000). There-
fore, we looked for whether the TSG101–hVPS28 complex
contributes directly to receptor trafficking. As a first step, we
examined whether the complex was localized to EGFR-
enriched endosomes.
A431 cells have a large complement of EGFR. At least
some of these were ubiquitinated upon ligand binding, since
EGFR immunoprecipitates isolated from cells shortly after
EGF internalization but not from untreated cells were la-
beled with a monoclonal antibody against protein–ubiquitin
conjugates, FK2 (Fig. 2 A). The intensity of ubiquitin stain-
ing fell sharply between 10 and 30 min after EGF internal-
ization (though residual labeling was still detected). In addi-
tion, the appearance of antiubiquitin staining was not
accompanied by any noticeable shift in mobility of the
EGFR, suggesting that only a very small proportion of the
receptor was ubiquitinated at any time. These data are con-
sistent with previous reports that ligand-induced ubiquitina-
tion of the EGFR is rapid and transient (Levkowitz et al.,
1998), though they might additionally indicate that receptor
ubiquitination is substoichiometric. Immunofluorescence
staining confirmed that EGF-rich endosomes contained
ubiquitinated proteins (Fig. 2 B). Surprisingly, endosomes
were strongly labeled for ubiquitinated proteins at later
times when the amount of ubiquitinated EGFR had fallen.
These data are consistent with ubiquitin functioning late on
the endocytic pathway and with endosomally associated pro-
tein(s) distinct from the EGFR being ubiquitinated as a con-
sequence of receptor internalization.
We examined the localization of the TSG101 complex af-
ter EGF had been internalized for 1 h, after which time it
had reached enlarged ubiquitin-rich endosomes and little
degradation of the receptor-ligand complex had occurred.
EGF was detected in early endosome-associated antigen 1
(EEA1)–positive compartments (Fig. 2 C). These also la-
beled with the polyubiquitinated protein-specific mono-
clonal antibody, FK1, and for TSG101 and hVPS28 (Fig. 2
C). The pattern of staining for ubiquitin, TSG101, and
hVPS28 was significantly different from that in nonstimu-
lated cells, indicating that EGFR internalization had affected
the localization of both ubiquitin and the TSG101–hVPS28
protein complex.
To further investigate links between ubiquitination of en-
dosomal proteins and receptor degradation, we used the pro-
teasome inhibitor, MG132, which has been demonstrated
previously to block mitogenic receptor degradation (Rocca
et al., 2001; van Kerkhof et al., 2001). Although it remains
unclear whether proteasomes are directly involved in recep-
Figure 3. Inhibition of proteasome function inhibits EGF degradation and prevents deubiquitination of endosomal proteins. (A, left) 
125I 
EGF was bound and internalized into A431 cells in the absence (control; C) or presence (M) of 5  M MG132 or with MG132 in cells which 
had also been preincubated for 3 h with 5  M MG132 (P). After the indicated times of internalization, medium was removed and assayed for 
degraded 
125I EGF. (A, right) 
125I EGF was bound and internalized into untreated A431 cells (C) or into cells to which MG132 was added 30 
min after internalization had begun (M). Samples were assayed for EGF degradation as above. All values are means of triplicate determinations   
SEM. (B) A431 Cells were incubated with 0.4  g/ml EGF at 4 C followed by 10, 30, or 120 min at 37 C as indicated. Cells were incubated 
with 5  M MG132 for 3 h before and during internalization (P), incubated with 5  M MG132 during internalization only (M), or otherwise 
untreated (C). Cell lysates were immunoprecipitated with anti-EGFR antibody, and bound fractions were Western blotted with anti-EGFR (top) 
or antiubiquitin (FK2; bottom). The samples containing peak FK2 labeling are indicated by asterisks. An immunoprecipitate from untreated 
cells is also shown (U). (C) Oregon green EGF was bound to A431 cells and internalized. Cells were chilled, incubated with saponin before 
fixation, and then analyzed for EGF content (green) and stained with FK2 antibody (red). (Top) Cells preincubated for 3 h with MG132 and 
then EGF internalized for 1 h with MG132. (Middle) EGF internalized for 1 h with MG132. (Bottom) EGF internalized for 30 min followed by 
a further 4.5 h with MG132. 
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tor degradation, it has been reported in the case of the inter-
leukin 2 receptor 
 
 
 
 chain that inhibition of proteasome
function is accompanied by defects in receptor sorting and
the elevation of levels of ubiquitin–receptor conjugate
(Rocca et al., 2001). Proteasome inhibition leads to a deple-
tion of free ubiquitin (Patnaik et al., 2000; Schubert et al.,
2000; Strack et al., 2000). This may arise from the inability
of deubiquitinating enzymes to function in the context of
stalled proteasomes, though other reasons are also possible.
As expected, preincubation of A431 cells with MG132 for 3 h
before EGF binding and during EGF internalization abol-
ished EGF degradation (Fig. 3 A, left). EGF degradation
was also substantially reduced upon incubating cells with an-
other proteasome inhibitor, lactacystin (unpublished data).
The small extent of EGF-dependent EGFR ubiquitination
observed in control cells was abolished by prior incubation
with MG132 so that ubiquitination of the receptor could
not be detected over background levels found in untreated
cells (Fig. 3 B, lane 1 compared with lane 2). Fluorescently
labeled EGF accumulated in small endosomes that were
only weakly labeled for ubiquitin (Fig. 3 C, top) and VPS28
(unpublished data). In contrast, when MG132 was added
only after EGF binding internalized EGF (whose degrada-
tion was substantially impaired) (Fig. 3 A left) entered en-
larged ubiquitin-enriched endosomes as in control cells (Fig.
3 C, middle). Much EGF remained associated with ubiq-
uitin-enriched endosomes even after a 5-h internalization
(unpublished data). However, interestingly, EGFR ubiquiti-
nation and deubiquitination was unaffected by MG132
(Fig. 3 B).
These data suggest that the kinetics of EGFR and endoso-
mal protein deubiquitination may occur at different rates,
with the receptor being deubiquinated much earlier than
other endosomal proteins. This was further demonstrated by
addition of MG132 30 min after EGF internalization when
the population of ubiquitinated EGFR had already dimin-
ished. EGF degradation remained substantially reduced
(Fig. 3 A, right), and much undegraded EGF was associated
with clustered endosomes that labeled strikingly for ubiq-
Figure 4. Anti-hVPS28 inhibits EGF degradation. 
HeLa cells were microinjected with preimmune IgG 
(left) or anti-hVPS28 (right). Texas red EGF was 
internalized as indicated, and cells were examined 
for EGF. Injected cells were detected by DAPI stain-
ing. Confocal settings were identical for all samples.
Figure 5. Anti-hVPS28 causes ubiquitinated proteins to accumulate 
on endosomes. HeLa cells were microinjected with preimmune IgG 
(PI) or anti-hVPS28 antibody (VPS28). Oregon green EGF was inter-
nalized for 3 h. Alternatively, Oregon green EGF was bound and
internalized into cells treated with either 100  M leupeptin (leu) or 
0.3 mM primaquine (prim). Cells were permeabilized with saponin, 
fixed, visualized for EGF (EGF), and stained with FK2 monoclonal 
antibody. Microinjected cells were identified by DAPI staining 
(unpublished data). Confocal settings were identical for all EGF 
labeling but were altered for ubiquitin staining to prevent saturation. 
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uitin (Fig. 3 C, bottom). Together, these data suggest that
deubiquitination of the EGFR and loss of ubiquitin labeling
from endosomes can be uncoupled experimentally and
hence are consistent with EGFR sorting being accompanied
by the ubiquitination of other endosomal proteins.
 
Impairing class E protein complexes retards EGF 
degradation and causes ubiquitinated proteins to 
accumulate on endosomes
 
To provide functional evidence that the TSG101–hVPS28
complex acts directly in receptor trafficking, we examined the
fate of EGF in cells microinjected with anti-hVPS28. Anti-
hVPS28 did not impair EGF internalization, since EGF la-
beling was similar after a 30-min internalization in cells in-
jected with either anti-hVPS28 or control antibody (Fig. 4).
In HeLa cells, degradation of intracellular EGF is essentially
complete after 3 h. However, cells that had been microin-
jected with anti-hVPS28 retained substantial EGF labeling at
this time (Fig. 4). At 3 h, the maximal intensity of EGF stain-
ing in anti-hVPS28 injected cells (
 
n
 
 
 
  
 
35) was 467 
 
 
 
 31%
compared with that in control injected cells (
 
n
 
 
 
  
 
31).
The effect of anti-hVPS28 on EGF degradation was spe-
cific, since it did not affect the kinetics of transferrin recy-
cling. Compared with noninjected cells, cells injected with
anti-hVPS28 took up comparable levels of Texas red–conju-
gated transferrin after 15 min (112 
 
 
 
 9%; 
 
n 
 
  
 
30 compared
with uninjected cells, 
 
n 
 
  
 
42). Likewise, loss of transferrin
labeling after a 2-h chase was unaffected by microinjection
of anti-hVPS28 (the residual signal being 102 
 
 
 
 11% [
 
n
 
  
 
31] in injected cells relative to uninjected cells [
 
n
 
 
 
  
 
42]).
Given that the TSG101–hVPS28 complex binds to ubiq-
uitin and contributes to endosomal sorting, we examined
Figure 6. Depletion of TSG101 affects EGF trafficking 
and endosomal ubiquitination. (A) HeLa cells were 
mock transfected (lane 1) or transfected with siRNA 
against Tsg101 (lane 2). Cell extracts were Western 
blotted for TSG101 (top) or tubulin as a control (bottom). 
(B) HeLa cells were mock transfected (M; top) or 
transfected with siRNA against Tsg101 (T; bottom) 
and stained for EEA1 or CD63 as indicated. (C). Oregon 
green EGF was internalized for the indicated times into 
mock-transfected HeLa cells (top) or cells transfected 
with siRNA against Tsg101 (bottom). Cells were 
analyzed for EGF (green) and stained with DAPI (blue) 
and with FK2 monoclonal antibody followed by Texas 
red 2  antibody (red). (D). EGF was bound and internal-
ized into mock-transfected HeLa cells (left) or cells 
transfected with siRNA against Tsg101 (right). Cell 
lysates were made after the indicated times of EGF
internalization and Western blotted for EGFR. 
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whether interfering with its function affected the release of
ubiquitin from endosomally associated ubiquitin–protein
conjugates that had formed as a consequence of receptor in-
ternalization. Indeed, microinjection of cells with anti-
hVPS28 caused a dramatic increase in the level of FK2 label-
ing of EGF-positive endosomes (Fig. 5). The accumulation
of ubiquitin–protein conjugates was largely dependent on
EGFR internalization; the maximum intensity of FK2 label-
ing associated with cytoplasmic structures was 508 
 
  
 
23%
in microinjected cells to which EGF had been bound and in-
ternalized (
 
n
 
 
 
  
 
21) compared with that observed in micro-
injected cells that had been mock treated (
 
n
 
 
 
  
 
22). In addi-
tion, little increase in endosomal FK2 labeling was observed
in uninjected cells that had internalized EGF while being
treated with the lysosomal protease inhibitor leupeptin or
with primaquine, which blocks endosomal sorting by col-
lapsing the pH gradient (Fig. 5). Hence, the accumulation
of ubiquitinated moieties was not simply a consequence of
preventing the degradation of receptor–ligand complexes.
The effects of disrupting the TSG101–VPS28 complex on
receptor trafficking and endosomal ubiquitination were also
investigated using small interfering RNA (siRNA) to deplete
cellular TSG101. Transfection of HeLa cells with a siRNA
duplex matching a nucleotide sequence within the coding
region of 
 
Tsg101
 
 caused a near total loss of cellular TSG101
protein after 48 h of culture (Fig. 6 A). The loss was specific,
since levels of tubulin were unaffected (Fig. 6 A). Cell cul-
tures transfected with the TSG101 siRNA were substantially
impaired in their ability to degrade 
 
125
 
I-labeled EGF (un-
published data), consistent with data obtained using a mu-
tant NIH 3T3 cell line that exhibits reduced expression lev-
els of TSG101 (Babst et al., 2000).
Depletion of TSG101 had a striking effect on the mor-
phology of endosomal compartments. Late endosomal com-
partments that stained for CD63 were highly vacuolated and
clustered compared with mock-treated cells (Fig. 6 B). In
addition, the early endocytic marker EEA1 was affected (Fig.
6 B). Although much EEA1 remained associated with small
punctate structures, additional labeling was clustered in
larger structures. A similar degree of redistribution was ob-
served for the transferrin receptor (unpublished data). These
alterations in membrane distribution were confined to endo-
somal compartments (unpublished data). The effect of
TSG101 depletion on EGF trafficking was also observed by
fluorescence microscopy (Fig. 6 C). Internalized EGF accu-
mulated at foci, often toward the center of cells. Hence, al-
though TSG101 depletion may enhance EGF recycling
(Babst et al., 2000) a significant portion of EGF enters a
compartment from which it can no longer be sorted effi-
ciently. Significantly, label accumulated adjacent to vacu-
olated membranes, most likely endosomal compartments,
which were highly enriched for ubiquitin–protein conju-
gates. Although knock-down of TSG101 caused a profound
relocalization of cellular ubiquitin to endosomes in conjunc-
tion with impairment of EGF sorting, we found no evidence
for alterations in the ubiquitination of the EGFR itself. In
either mock-treated or TSG101 siRNA-treated cells, EGF
binding and internalization was not accompanied by signifi-
cant EGFR ubiquitination as judged by changes in mo-
lecular weight (Fig. 6 D). siRNA duplexes targeted against
other coding sequences, including lamin A, affected neither
TSG101 levels, EGF degradation, or ubiquitin accumula-
tion. In addition, the TSG101 siRNA did not affect the rat
cell line NRK (unpublished data).
These data are consistent with impairment of TSG101–
VPS28 preventing the release of ubiquitin from endosomal
ubiquitin–protein conjugates. Likewise, impairing Hrs also
blocked receptor sorting and release of ubiquitin. Consistent
with previous reports (Komada et al., 1997), exogenously
expressed Hrs localized to enlarged compartments (Fig. 7)
that stained for early endosomal markers (unpublished
data). These compartments partially colocalized with mark-
Figure 7. Hrs expression inhibits EGF 
degradation. HeLa cells were transfected 
with Hrs. Oregon green EGF was bound 
and internalized for the indicated times. 
Cells were visualized for EGF (green) 
and stained with anti-Hrs IgG (red). 
Untransfected cells are indicated by 
an asterisk. 
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ers for the late endocytic pathway (unpublished data), im-
plying that overexpression of Hrs causes defective endocytic
sorting. To assess this in more detail, we examined the inter-
nalization and degradation of EGF. Hrs overexpression did
not impair the internalization of EGF, since transfected cells
were similarly labeled with EGF as neighboring untrans-
fected cells after short periods of internalization (Fig. 7). At
later times, internalized EGF reached compartments en-
riched in expressed Hrs (though not all Hrs-enriched
compartments were labeled). A significant portion of EGF
remained in these compartments even after 3 h internaliza-
tion, in contrast to neighboring cells where the majority of
EGF was degraded.
Cells expressing Hrs showed striking changes in ubiquitin
distribution with dramatic localization of ubiquitin–protein
conjugates to Hrs-enriched endosomes such that the endoso-
mal ubiquitin staining was substantially more intense than
over the nucleus (Fig. 8 A). No staining of Hrs-induced endo-
somes with antibodies against proteasome components was
observed (Fig. 8 A), implying that the redistribution of ubiq-
uitin was not simply a consequence of recruiting misfolded
proteins to the Hrs endosomes. This apparent relocalization
of cellular ubiquitin might be due merely to the accumulation
of endosomal ubiquitinated protein(s) with unusual reactivity
toward the FK monoclonal antibodies under the fixation con-
ditions employed by us. However, this is unlikely since the
localization of epitope-tagged ubiquitin was altered from a
predominantly nuclear and cytosolic distribution to an endo-
somal distribution upon coexpression of Hrs (Fig. 8 B).
 
Discussion
 
The molecular machinery that directs receptors to the late en-
docytic pathway in mammalian cells is not known, though
ubiquitination is thought to play an important role. We have
focused our attention on mammalian orthologues of yeast
class E vps proteins, since these are likely to act at this sorting
step. Here we have shown that both the TSG101–VPS28-
and Hrs-containing complexes bind ubiquitin. The affinity
appears moderate as would be expected of interactions no
doubt normally regulated by additional factors. The ATP-
independent binding of cytosolic TSG101–hVPS28 to ubiq-
uitin might be expected given that the TSG101 Ubc domain
lacks the critical cysteine residue for formation of a ubiquitin
thioester. However, this is in contrast to the case of the
TSG101-related Mms2p, which interacts with ubiquitin in
combination with Ubc13p (Hofmann and Pickart, 1999).
Cells with reduced levels of TSG101 are impaired in mi-
togenic receptor down-regulation and show enhanced EGF
recycling (Babst et al., 2000). Our data using siRNA to de-
plete cellular TSG101 largely confirm these observations,
though they show that a significant amount of internalized
EGF is retained in a nondegradative endocytic compart-
ment. In contrast to these earlier studies, we find that
TSG101 depletion induces aberrant morphology in multiple
endocytic compartments. The discrepancy between these
findings may perhaps be accounted for by differences in the
level to which TSG101 is depleted in each experimental sys-
tem. Depletion experiments provide limited evidence that
TSG101 acts directly to promote receptor trafficking, par-
ticularly since this event would be sensitive to changes in the
levels of either ubiquitin or ubiquitin-interacting compo-
nents that might be influenced by loss of TSG101. How-
ever, we have demonstrated that TSG101 and VPS28 are lo-
calized to ubiquitin-rich endosomes during ligand-induced
EGFR internalization. Additionally, antibodies to VPS28
Figure 8. Hrs expression causes relocalization of ubiquitinated 
proteins. (A) HeLa cells were transfected with untagged Hrs, 
permeabilized in saponin, fixed, and stained for Hrs (left) and with 
FK2 or FK1 antiubiquitin–protein conjugates, or with HP810 anti-
proteasome as indicated (right). Untransfected cells are denoted by 
an asterisk. (B) HeLa cells were transfected with His6-tagged ubiquitin 
alone (top) or with His6-tagged ubiquitin and EGFP-Hrs (bottom). 
Cells were fixed directly in methanol without prior permeabilization 
and visualized for Hrs (left) and stained using anti-His antibody (right). 
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specifically impair EGF degradation without affecting other
endosome-associated functions, such as delivery of receptors
to the sorting endosome and transferrin receptor recycling.
Importantly, though our data support a direct role for
TSG101–VPS28 in receptor trafficking they do not pre-
clude the complex from fulfilling other cellular roles involv-
ing ubiquitin recognition (Li and Cohen, 1996; Hittelman
et al., 1999).
In further support of a direct role of class E vps proteins in
ubiquitin-dependent receptor trafficking, we have shown
that disruption of class E vps function by three independent
means causes dramatic relocalization of cellular ubiquitin to
endocytic compartments. The full cause of this relocaliza-
tion remains unclear. Possibly, impairment of TSG101–
VPS28 function prevents recruitment of further cytosolic
components required for receptor sorting and that disassem-
bly of the full complex is coupled to removal of ubiquitin
chains. Consistent with this, expression of dominant nega-
tive mammalian VPS4, which may link the disassembly of
such a complex to ATP hydrolysis (Babst et al., 1998;
Bishop and Woodman, 2000), also causes dramatic endoso-
mal accumulation of ubiquitinated proteins (unpublished
data). Hrs might play a more direct role in releasing ubiq-
uitin, since an Hrs-binding protein interacts with the de-
ubiquitinating enzyme UBPY (Kato et al., 2000). Cytosolic
Hrs is part of a 500-kD complex (unpublished data). We
speculate that exogenously expressed Hrs, which binds to
endosomes via its FYVE and coiled coil domains (Raiborg et
al., 2001) (and which presumably interacts with ubiqui-
tinated moieties on the endosome surface), would displace
endogenous Hrs complexes and thus prevent recruitment of
UBPY. We have been unable to analyze any further the
functional significance of Hrs binding to ubiquitin since, as
expected, the UIM is not solely necessary for endosomal lo-
calization of Hrs or the impairment of EGF trafficking by
Hrs overexpression.
The cellular ubiquitinated substrates for TSG101 and Hrs
remain to be identified, and we have been hampered in this
respect by our inability to stabilize receptor-dependent ubiq-
uitination events in cell extracts. Candidates include the
mitogenic receptors themselves. By analogy, the yeast Vps23p-
containing ESCRT-1 complex binds directly to ubiqui-
tinated carboxypeptidase S precursor (Katzmann et al., 2001).
Indeed, we have detected a weak coimmunoprecipitation
of the EGFR with the TSG101 complex, though this is
independent of receptor ubiquitination (unpublished data).
However, we anticipate that recruitment of mammalian
TSG101 may be more complex. Endocytic compartments
within TSG101-depleted cells accumulate striking levels of
ubiquitinated proteins, yet we find no evidence that the
EGFR is hyperubiquitinated. In addition, we have shown
using a proteasome inhibitor that accumulation of ubiqui-
tinated proteins within EGFR-enriched endosomes can be
experimentally uncoupled from ubiquitination of the EGFR
itself. The failure to increase levels of ubiquitinated EGFR
under conditions where deubiquitination of endosomal pro-
teins is apparently so diminished raises the possibility that
ubiquitinated proteins other than the receptor are important
for endosomal sorting and hence might act as the principle
substrates for Hrs and TSG101 binding. These data are also
completely consistent with recent findings that endosomal
sorting of a truncated growth hormone receptor is critically
dependent on a ubiquitin-recruiting motif within the recep-
tor but does not require receptor ubiquitination (van
Kerkhof et al., 2001). Furthermore, TSG101 interacts via its
Ubc-like domain with a highly conserved peptide motif
within the Pr55
 
Gag
 
 protein of HIV type 1 (Garrus et al.,
2001; Martin-Serrano et al., 2001; VerPlank et al., 2001),
which is absent from mitogenic receptors, including EGFR.
Interestingly, artificial covalent attachment of ubiquitin to
HIV Pr55
 
Gag
 
 enhances TSG101 Ubc domain binding (Gar-
rus et al., 2001).
Our data place mammalian class E vps proteins at the cen-
ter of ubiquitination-dependent receptor sorting. They ex-
tend the finding that defects in yeast Doa4p, a deubiqui-
tinating enzyme, are suppressed by class E 
 
vps
 
 mutants
(Amerik et al., 2000). At present, we cannot discriminate
between models that favor ubiquitin recruiting a specific en-
dosomal sorting machinery and those that imply that pro-
teasome function is important for endosomal sorting. How-
ever, our finding that the TSG101 complex contributes
directly to mitogenic receptor sorting supports recent evi-
dence that the yeast ESCRT-1 complex of Vps23/28/37p
promotes the ubiquitin-dependent biosynthetic sorting of
vacuolar precursors (Katzmann et al., 2001). In yeast, inter-
fering with Vps23p blocks either directly or indirectly the
localization of receptors to the internal vesicles of multivas-
cular body. We now aim to address if this specific stage is
blocked when mammalian class E vps protein function is
impaired.
 
Materials and methods
 
DNA manipulations
 
Mouse Hrs (mHrs) cDNA was provided by Dr. Naomi Kitamura (Tokyo In-
stitute of Technology, Tokyo, Japan) and cloned into pGEX-4T2 (Amer-
sham Pharmacia Biotech) or into pcDNA3.1 lacking the epitope tag. Hrs-
 
 
 
UIM-1 lacked amino acids 259–273, and Hrs(AQ) contained E260A/
E261Q substitutions within the putative UIM. Alternatively, Hrs was
cloned into the vector pEGFP (CLONTECH Laboratories, Inc.) to generate
pEGFP-mHrs. TSG101 deletions were as described previously (Bishop and
Woodman, 2001), with TSG101(Ubc) made by deleting amino acids 137–
388. All mutagenesis (QuickChange [Stratagene] or cassette) was con-
firmed by sequencing. His-tagged ubiquitin was expressed using the
pMT107 construct, a gift from Dirk Bohmann (European Molecular Biol-
ogy Laboratory, Heidelberg, Germany).
 
Antibodies and reagents
 
Sheep were immunized with GST-mHrs purified from bacterial inclusion
bodies. For fluorescence microscopy, cells were stained with an IgG frac-
tion at a concentration that detected expressed but not endogenous Hrs.
The following monoclonal antibodies were against ubiquitinated proteins
(FK1, which recognizes only polyubiquitin–protein conjugates, and FK2,
which recognizes both mono- and polyubiquitinated conjugates; Affiniti
BioRegeants, Inc.), EEA1 (Transduction Laboratories), EGFR (clone 29.1.1;
Sigma-Aldrich), 20S proteasome (HP810; Affinity BioReagents, Inc.), tubu-
lin (TAT1; from K. Gull, University of Manchester, Manchester), TSG101
(GeneTex), CD63 (a gift from Fedor Berditchevski, University of Birming-
ham, Birmingham, UK). Also used were rabbit anti-Ubc1 (Affiniti
BioRegeants, Inc.) and affinity purified anti-hVPS28 (Bishop and Wood-
man, 2001). HRP-conjugated antibodies (Dako) were used for ECL blot-
ting. MG132 was purchased from Calbiochem and stored at –20
 
 
 
C in
DMSO.
 
Cells
 
Cells were grown in DME (GIBCO BRL) containing 10% FCS. Cells were
transfected with DNA constructs using FuGene (Roche) and analyzed after 
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16–24 h. For siRNA experiments, 21 nucleotide RNA duplexes corre-
sponding to the Tsg101 coding nucleotides AACGATGGCAGTTCCAGG-
GAA with symmetric 2 nucleotide 3
 
 
 
 (2’-deoxy) thymidine overhangs
(sense, 5
 
 
 
 CGAUGGCAGUUCCAGGGAAdTdT; antisense, 5
 
 
 
 UUCCCUG-
GAACUGCCAUCGdTdT) were synthesized and annealed (Dharmacon
Research). HeLa cells were transfected with 6 
 
 
 
l 20 
 
 
 
M siRNA duplex per
well of a 12-well dish using oligofectamine (Invitrogen) and standard pro-
cedures (Elbashir et al., 2001). Knock-down of cellular TSG101 was rou-
tinely observed after 48 h. For Western blot analysis of cell extracts, cells
were solubilized in buffer A containing 1% Triton X-100, and proteins
were precipitated immediately in chloroform/methanol before SDS PAGE.
For immunoprecipitations, cells were lysed in 0.4 ml boiling buffer A (100
mM NaCl, 1 mM MgCl
 
2
 
, 20 mM Hepes-NaOH, pH 7.4) containing 50 mM
NaF, 1 mM Na
 
3
 
VO
 
4
 
, and 1% SDS. Cleared samples were diluted into 5 vol
of buffer A containing 2% Triton X-100, incubated at 4
 
 
 
C overnight with
antibody and 10 
 
 
 
l protein A-sepharose, and then washed four times be-
fore preparation for SDS-PAGE. To measure degradation of 
 
125
 
I EGF, io-
dinated EGF (50 
 
 
 
Ci/
 
 
 
g) was bound (50 ng/ml) to A431 cells for 1 h at 4
 
 
 
C
with CO
 
2
 
-independent medium (GIBCO BRL) containing 2 mg/ml BSA
(BM). Cells were washed and incubated in 1 ml BM. As indicated, medium
was removed and TCA added to 10%. After 1–2 h on ice, samples were
centrifuged, and the supernatant was counted for radioactivity.
 
Fluorescence microscopy
 
Cells were fixed in 3.5% (wt/vol) PFA with a 0.05% saponin pretreatment
as indicated or with methanol. Secondary antibodies were from Jackson
ImmunoResearch Laboratories. For EGF uptake, cells were washed in PBS
and incubated in BM containing 0.4 
 
 
 
g/ml Oregon green or Texas red EGF
(Molecular Probes), washed, and then incubated at 37
 
 
 
C. For transferrin
uptake, 20 
 
 
 
g/ml Texas red transferrin (Molecular Probes) was bound and
internalized in medium containing 0.1 mg/ml transferrin and 50 
 
 
 
M des-
ferroxamine (Ciba). Cells were examined using a Leica NT confocal micro-
scope or an inverted Olympus IX-70 linked to a Delta Vision system (Ap-
plied Precision, Inc.). Quantitation was performed using an Olympus BX60
microscope linked to a cooled slow-scan CCD camera (Roper Scientific)
driven by Metamorph software (Universal Imaging Corp.). Images were
processed using Adobe Photoshop
 
®
 
 5.0.
 
Microinjection
 
Antibodies were dialyzed against 48 mM K
 
2
 
HPO
 
4
 
, 4.5 mM KH
 
2
 
PO
 
4
 
, 14
mM NaH
 
2
 
PO
 
4
 
, pH 7.2, and concentrated. Antibody solutions (0.5 mg/ml)
containing 25 
 
 
 
g/ml DAPI were injected using an Eppendorf 5171 micro-
manipulator and microinjector. Cells were normally incubated for 
 
 
 
1 h at
37
 
 
 
C between microinjection and the start of internalization assays.
 
Ubiquitin binding
 
In vitro translation (Promega) products (5 
 
 
 
l) were diluted in 250 
 
 
 
l buffer
A containing 1% Triton X-100 and incubated for 2 h at 4
 
 
 
C with 10 
 
 
 
l pre-
washed ubiquitin- (Affinity BioReagents, Inc.) or GSH-agarose beads,
washed four times in buffer A, and boiled for SDS PAGE. Gels were ana-
lyzed by phosphorimaging. For native proteins, HeLa cytosols were incu-
bated for 15 min with 50 IU/ml hexokinase and 5 mM glucose final to de-
plete ATP and desalted into buffer A. Samples (
 
 
 
1 mg total protein) were
incubated with 20 
 
 
 
l ubiquitin- or GSH-agarose beads as above and then
analyzed by Western blotting.
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